Healthcare -
Biotechnology - NASDAQ - US
$ 3.9
-3.23 %
$ 272 M
Market Cap
-0.74
P/E
PHAT - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities PHAT - Phathom Pharmaceuticals, Inc.
-135 K
LAST VALUE
63.99%
2 YEAR CAGR
64.88%
5 YEAR CAGR
0.00%
10 YEAR CAGR